8-K: Pasqal Completes SPAC Merger, Secures $360M for Quantum Growth
Current Report (Form 8-K) / Business Combination Completion
Pasqal Holding SA and Bleichroeder Acquisition Corp. II announced the successful completion of their business combination, with Pasqal set to trade on Nasdaq under PSQL.
Summary
- Bleichroeder Acquisition Corp. II (Bleichroeder) and Pasqal Holding SAS have successfully completed their business combination, with the surviving entity renamed Pasqal Holding SA.
- The transaction, effective August 27, 2026, establishes Pasqal as a public company with approximately $360 million in cash available.
- Pasqal's ordinary shares and warrants are expected to commence trading on The Nasdaq Stock Market on August 28, 2026, under the ticker symbols PSQL and PSQLW, respectively.
- The capital raised will be used to accelerate the deployment of Pasqal's quantum computing platform, advance its technology roadmap towards fault-tolerant quantum computing, and expand commercial adoption.
- All directors and officers of Bleichroeder resigned effective upon the completion of the business combination.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive development, marking the successful completion of a business combination and establishing a public capital foundation for Pasqal.
Positives
- Successful completion of the business combination between Pasqal and Bleichroeder Acquisition Corp. II.
- Pasqal is now a public company with approximately $360 million in cash available to fund growth initiatives.
- The company has a clear roadmap for advancing its neutral-atom quantum computing technology towards fault-tolerant capabilities.
- Pasqal has seven QPUs deployed and three more in production, with a growing fleet available globally through cloud access.
- The company has established commercial and research applications across key industries like energy, financial services, and materials science.
- Expected commencement of trading on Nasdaq under ticker symbols PSQL and PSQLW on August 28, 2026.
Negatives
- The filing details the termination of the original Registration Rights Agreement and the superseding of lock-up provisions from a previous Letter Agreement.
- Bleichroeder's Class A ordinary shares, warrants, and units will cease trading on Nasdaq.
Risks
- Pasqal is pursuing an emerging technology and faces significant technical challenges, with no guarantee of commercialization or market acceptance.
- The company relies on strategic partners and other third parties for its operations.
- Risks related to maintaining, protecting, and defending intellectual property rights.
- General economic, political, social, and business conditions could impact Pasqal's performance.
- Uncertainty or changes with respect to laws and regulations.
- The risk that the business combination disrupts Pasqal's current plans and operations.
- Risks related to Pasqal's indebtedness.
Future Outlook
Pasqal intends to use the capital to accelerate the deployment of its quantum computing platform, advance its technology roadmap towards fault-tolerant quantum computing, broaden access to its cloud and software platform, deepen integration with classical high-performance computing infrastructure, and scale its commercial operations globally.
Management Comments
- "Today is not a finish line; it is an acceleration point," said Wasiq Bokhari, Chief Executive Officer of Pasqal.
- "Pasqal was built to take neutral-atom quantum computing from foundational science to industrial-scale deployment."
- "We have deployed quantum systems in real operating environments, connected our processors to the computing infrastructure customers already use and established a roadmap built on a single hardware platform that delivers state-of-the-art analog quantum computing today and is designed to enable industry-leading fault-tolerant quantum computing in the future."
- "Our systems operate in standard data center environments and are built to scale with enterprise workloads."
- "As a public company, we will have a stronger platform to move faster, serve customers around the world and build enduring value for shareholders."
Industry Context
StockSavvy.ai notes that this business combination positions Pasqal, a leader in neutral-atom quantum computing, to compete more effectively in the rapidly evolving quantum computing landscape. The infusion of capital is critical for scaling operations and advancing technology in a field characterized by significant R&D investment and long development cycles.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Directors and Officers of Bleichroeder Acquisition Corp. II | Various | N/A (Resigned) | August 27, 2026 | Completion of the business combination. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Termination of Agreements | Termination of the Registration Rights Agreement dated January 7, 2026, and superseding of lock-up provisions in the Letter Agreement dated January 7, 2026. | August 27, 2026 | Standard procedural changes following a business combination, establishing new registration rights and lock-up agreements. |
| New Agreements | Entry into an Amended and Restated Registration Rights Agreement and Lock-Up Agreements by New Pasqal, the Sponsor, and certain securityholders of Pasqal. | August 27, 2026 | Establishes new registration rights and transfer restrictions for key stakeholders in the combined entity. |
Stakeholder Impact
- Shareholders: Bleichroeder shareholders now hold shares in the combined entity, Pasqal Holding SA, with expected trading on Nasdaq. New registration rights and lock-up agreements are in place.
- Employees: The business combination is expected to provide a stronger platform for growth, potentially leading to expanded opportunities.
- Customers: Continued access to Pasqal's quantum computing platform and services, with potential for accelerated innovation and deployment.
- Suppliers: Potential for increased business as Pasqal scales its operations and deployment.
- Creditors: The financial foundation of the combined entity is strengthened by the capital infusion.
Next Steps
- Pasqal Holding SA's ordinary shares and warrants are expected to begin trading on The Nasdaq Stock Market on August 28, 2026, under ticker symbols PSQL and PSQLW.
- Accelerate global deployment of its quantum computing platform.
- Advance its technology roadmap toward fault-tolerant quantum computing.
- Broaden access to its cloud and software platform.
- Deepen integration with classical high-performance computing infrastructure.
- Scale its commercial operations globally.
Key Dates
| Date | Description |
|---|---|
| January 7, 2026 | Date of the Registration Rights Agreement and the Letter Agreement. |
| February 28, 2026 | Date of the initial Agreement and Plan of Merger. |
| May 26, 2026 | Date of Amendment No. 1 to the Agreement and Plan of Merger and Assignment and Assumption Agreement. |
| June 25, 2026 | Date of Amendment No. 2 to the Agreement and Plan of Merger. |
| July 22, 2026 | Date of Amendment No. 3 to the Agreement and Plan of Merger. |
| August 5, 2026 | Date the SEC declared effective the registration statement on Form F-4 (Proxy Statement/Prospectus). |
| August 25, 2026 | Date Bleichroeder shareholders approved the business combination. |
| August 27, 2026 | Closing Date of the business combination; effective date of mergers and change of control. |
Recommendation
holdThe completion of the business combination and the capital infusion are positive developments. However, the company operates in a highly speculative and capital-intensive emerging technology sector. While the outlook is promising, significant technical and market adoption risks remain. A 'hold' recommendation reflects the potential for future growth balanced against the inherent uncertainties of the quantum computing industry.
Keywords
quantum computing, neutral-atom, SPAC, business combination, Nasdaq listing, Pasqal Holding SA, Bleichroeder Acquisition Corp. II, fault-tolerant quantum computing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.